Acne is a chronic disease ofthe pilosebaceous follicle that affects mainly adolescents. It causes polymorph cutaneous lesions that may leave scars after regression. It is characterized by alternation ...

Credit: Getty Images. The Food and Drug Administration (FDA) has approved Amzeeq (minocycline; Foamix) topical foam 4% for the treatment of inflammatory lesions of non-nodular moderate to severe acne ...

Please provide your email address to receive an email when new articles are posted on . Acne vulgaris may be driven by underlying systemic, immune-inflammatory pathways. Addressing those underlying ...

Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer has completed a Phase 1 trial titled “A Phase 1, Randomized, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A multi-center, prospective, open-label, single arm ...

Acne vulgaris has a substantial impact on a patient’s quality of life, affecting both self-esteem and psychosocial development.1 Patients and physicians are faced with many over-the-counter and ...

A number of physical therapies are available for treating active acne, although their success is variable and some require considerable skill to perform. Glycolic acid and salicylic acid peels have ...

The first FDA-approved acne drug with a first-in-class mechanism of action in nearly 40 years launched in the United States in November 2021 after being approved in August 2020. The first-in-class ...

Acne vulgaris is a long-term condition that can have lasting physical and psychological effects. Patient education is crucial to improve adherence to treatment Abstract Acne is the most common skin ...

Acne is one of the most common skin conditions seen in general practice. Acne vulgaris – the most prevalent form – affects more than 80% of teenagers and young adults (in some countries, it may be as ...